B-cell activation may also influence tumor prognosis, by producing antibodies against tumor antigens and by activating of a specific B-cell subset (i.e., Breg) that secrete anti-inflammatory mediators (e.g., IL-10) and convert T cells to regulatory T cells (Treg), thus attenuating anti-tumor immune responses [30]. Here, IL10 is linked to neoplasm.